期刊论文

【摘要】

Achalasia is a primary esophageal motility disorder characterized by the loss of inhibitory neurons in the myenteric plexus, resulting in impaired relaxation of the esophagogastric junction. Achalasia is an incurable disease, and the treatment modalities are aimed at disruption of the esophagogastric junction and vary widely from pharmacological to endoscopic to surgical. Traditional endoscopic therapy includes pneumatic dilation, botulinum toxin injection, and peroral endoscopic myotomy. This review aims to provide an overview of the endoscopic management of achalasia, while focusing on the utilization of peroral endoscopic myotomy and other novel approaches.

【授权许可】

CC BY-NC
© The Author(s), 2021

【预览】

附件列表
Files	Size	Format	View
RO202212206027600ZK.pdf	943KB	PDF	download
Figure 4.	468KB	Image	download
Table 1.	121KB	Table	download
Table 2.	675KB	Table	download
Table 3.	889KB	Table	download

【图表】

Figure 4.

【参考文献】

[1]
[2]
[3]
[4]
[5]
[6]
[7]
[8]
[9]
[10]
[11]
[12]
[13]
[14]
[15]
[16]
[17]
[18]
[19]
[20]
[21]
[22]
[23]
[24]
[25]
[26]
[27]
[28]
[29]
[30]
[31]
[32]
[33]
[34]
[35]
[36]
[37]
[38]
[39]
[40]
[41]
[42]
[43]
[44]
[45]
[46]
[47]
[48]
[49]
[50]
[51]
[52]
[53]
[54]
[55]

Therapeutic Advances in Gastrointestinal Endoscopy
Insights into the endoscopic management of esophageal achalasia
Review
Mouen A. Khashab¹ Elizabeth Brindise² Rami El Abiad³
[1] Division of Gastroenterology and Hepatology, The Johns Hopkins Hospital, Baltimore, MD, USA;Division of Gastroenterology and Hepatology, The University of Iowa, Iowa City, IA, USA;null;
关键词: achalasia; EndoFLIP; peroral endoscopic myotomy;
DOI : 10.1177/26317745211014706
received in 2021-01-15, accepted in 2021-04-07, 发布年份 2021
来源: Sage Journals
PDF


	文献评价指标
	下载次数：0次	浏览次数：0次

【 摘 要 】

【 授权许可】

【 预 览 】

【 图 表 】

【 参考文献 】

【摘要】

【授权许可】

【预览】

【图表】

【参考文献】